PMID: 9653163Jul 8, 1998Paper

Altered peptide ligands induce quantitatively but not qualitatively different intracellular signals in primary thymocytes

Proceedings of the National Academy of Sciences of the United States of America
Lesley A SmythD Kioussis

Abstract

Interaction of the T cell receptor (TCR) with peptide/major histocompatibility complexes (MHC) in the thymus is of critical importance for developing thymocytes. In a previous study, we described an antagonist peptide that inhibited negative selection of transgenic thymocytes induced by an agonist peptide. In this study we show that this antagonist peptide can induce positive selection of CD8(+) thymocytes more efficiently than the agonist or the weak agonist peptides, whereas the opposite is true for their ability to cause negative selection. The intracellular signals induced in thymocytes by such peptides after TCR ligation was examined in CD4(+)8(+) double-positive thymocytes from F5/beta2mo/Rag-1(o) transgenic mice. TCR ligation with either the agonist, weak agonist, or antagonist peptide variants resulted in hyperphosphorylation of CD3zeta, CD3epsilon, ZAP-70, Syk, Vav, SLP-76, and pp36-38. The extent of phosphorylation of these intracellular proteins correlated with the efficiency with which the peptide analogs induced apoptosis of immature thymocytes. Unexpectedly, there was no correlation between the upstream TCR signaling pathways analyzed and the capacity of the different peptides to induce positive selection.

References

Dec 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C MamalakiD Kioussis
Nov 11, 1994·Science·E W ShoresP E Love
Apr 1, 1995·International Immunology·P O Ericsson, H S Teh
Mar 31, 1995·The Journal of Biological Chemistry·J K JackmanP R Findell
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·D M PageH M Grey
Jan 14, 1994·Cell·K A HogquistF R Carbone
Mar 1, 1996·European Journal of Immunology·O WilliamsD Kioussis
Mar 1, 1996·The Journal of Experimental Medicine·E SebzdaP S Ohashi
Aug 16, 1996·The Journal of Biological Chemistry·J Bubeck WardenburgP R Findell
Sep 1, 1996·The Journal of Experimental Medicine·L TuostoO Acuto
Sep 1, 1996·The Journal of Experimental Medicine·K HashimotoT Nakayama
Mar 1, 1997·Immunology Today·O WilliamsD Kioussis
Jan 1, 1997·Annual Review of Immunology·J Alberola-IlaR M Perlmutter
Aug 1, 1997·Immunology Today·G A Koretzky

❮ Previous
Next ❯

Citations

Sep 10, 2002·Bulletin of Mathematical Biology·H A Van Den BergD A Rand
Oct 14, 2003·Trends in Immunology·Lisa A Pitcher, Nicolai S C van Oers
Mar 3, 2001·Current Opinion in Immunology·K A Hogquist
Oct 18, 2003·Seminars in Immunology·Lisa M Minter, Barbara A Osborne
Jul 14, 2000·Immunity·P E Love, E W Shores
Jun 6, 2000·The Journal of Experimental Medicine·G E PriceD Moskophidis
Oct 4, 2000·The Journal of Experimental Medicine·E M SchaefferP L Schwartzberg
Apr 3, 2001·The Journal of Experimental Medicine·F Van LaethemO Leo
Feb 12, 2000·Molecular and Cellular Biology·X R Bustelo
Jun 8, 1999·Annual Review of Immunology·E SebzdaP S Ohashi
Nov 5, 2002·Annual Review of Immunology·Timothy K StarrKristin A Hogquist
Nov 25, 1998·Proceedings of the National Academy of Sciences of the United States of America·S C Jameson
Apr 3, 2003·Immunological Reviews·Victor L J TybulewiczLucinda F Reynolds
Feb 4, 2010·Journal of Cellular Biochemistry·D M SimonsP I Lelkes
Oct 22, 2009·The FEBS Journal·Emma Teixeiro, Mark A Daniels
Mar 5, 2003·Immunological Reviews·Lisa A PitcherNicolai S C van Oers
Aug 11, 1999·Seminars in Immunology·S MariathasanP S Ohashi
Aug 28, 2002·Immunity·Fabio R SantoriStephen C Jameson
Mar 23, 2001·Nature Immunology·N S van OersC A Slaughter
Mar 23, 2001·Nature Immunology·J R DorfmanR N Germain
Feb 7, 2004·The Journal of Biological Chemistry·Lucinda F ReynoldsVictor L J Tybulewicz
Aug 2, 2020·The FEBS Journal·Darina Paprckova, Ondrej Stepanek
Oct 23, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Uwe KoelschLuca Simeoni
Jul 4, 2001·European Journal of Immunology·O WilliamsH J Brady
Feb 10, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Blandine C MercierNathalie Bonnefoy-Bérard
Jul 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Masha Fridkis-HareliEllis L Reinherz
May 22, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·H E StefanskiK A Hogquist
Sep 7, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·K YasutomoR N Germain
Mar 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·H E StefanskiK A Hogquist
Aug 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lolita ZaliauskieneJames F Collawn
May 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lisa A PitcherNicolai S C van Oers
Sep 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sven MostböckHelen Sabzevari
Aug 5, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·B Lucas, R N Germain
Jul 9, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lisa A PitcherNicolai S C van Oers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis